AU2000272858A1 - Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments - Google Patents
Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicamentsInfo
- Publication number
- AU2000272858A1 AU2000272858A1 AU2000272858A AU7285800A AU2000272858A1 AU 2000272858 A1 AU2000272858 A1 AU 2000272858A1 AU 2000272858 A AU2000272858 A AU 2000272858A AU 7285800 A AU7285800 A AU 7285800A AU 2000272858 A1 AU2000272858 A1 AU 2000272858A1
- Authority
- AU
- Australia
- Prior art keywords
- hyperhomocysteinaemia
- medicaments
- treating
- caused
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10004651A DE10004651A1 (en) | 2000-02-03 | 2000-02-03 | Combination of antihypertensive agents with drugs that reduce homocysteine levels |
DE10004651 | 2000-02-03 | ||
PCT/EP2000/008801 WO2001056609A1 (en) | 2000-02-03 | 2000-09-08 | Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2000272858A1 true AU2000272858A1 (en) | 2001-08-14 |
Family
ID=7629642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2000272858A Abandoned AU2000272858A1 (en) | 2000-02-03 | 2000-09-08 | Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2000272858A1 (en) |
DE (1) | DE10004651A1 (en) |
WO (1) | WO2001056609A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7608640B2 (en) | 1999-03-02 | 2009-10-27 | Jallal Messadek | Glycine betaine and its use |
WO2003045359A2 (en) * | 2001-11-26 | 2003-06-05 | Astion Oncology Aps | Combination of cimetidine and cysteine derivatives for treating cancer |
BE1015608A6 (en) | 2003-07-15 | 2005-06-07 | Messadek Jallal | TREATMENT arteritis. |
EG24716A (en) * | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
EP1663174A1 (en) * | 2003-08-05 | 2006-06-07 | Galephar M/F | Single unit pharmaceutical composition comprising a mixture of a fibrate and a homocysteine reducing agent |
IL157397A (en) * | 2003-08-14 | 2013-03-24 | Dpharm Ltd | Compounds, pharmaceutical compositions comprising same and uses thereof for the preparation of a medicament for the treatment of epilepsy |
ITRM20030442A1 (en) * | 2003-09-26 | 2005-03-27 | Medosan Ind Biochimiche Riuni Te S R L | PHARMACEUTICAL COMPOSITION (STRESSEN) FOR THE TREATMENT OF HYPEROMOCISTEINEMIA. |
EP1768675A4 (en) * | 2004-07-09 | 2008-03-12 | Medicure Int Inc | Combination therapies employing nicotinic acid derivatives or fibric acid derivatives |
WO2006050581A2 (en) | 2004-11-10 | 2006-05-18 | Jallal Messadek | Betaine as agent against arthropod - or mosquito -borne diseases |
EP1681055A1 (en) * | 2005-01-13 | 2006-07-19 | PEJO Iserlohn Heilmittel-und Diät-GmbH & Co.KG | Pharmaceutical preparation for the treatment of elevated homocysteine level |
WO2006086856A1 (en) * | 2005-02-15 | 2006-08-24 | Messadek, Jallal | Combination therapeutic compositions and method of use |
MX2007013486A (en) | 2005-04-27 | 2008-03-14 | Jallal Messadek | Insulins combinations. |
CN100497337C (en) * | 2006-11-20 | 2009-06-10 | 淮北辉克药业有限公司 | Folacin dimethylbiguanide and process for production thereof |
CN103386130A (en) * | 2013-06-27 | 2013-11-13 | 深圳奥萨医药有限公司 | ACE inhibitor/thiazide diuretic/5-methyltetrahydrofolate pharmaceutical composition and applications |
US10016379B2 (en) | 2015-10-30 | 2018-07-10 | Robin L. Webb | Method of treatment for third spacing |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008221A (en) * | 1996-11-06 | 1999-12-28 | Bristol-Myers Squibb Company | Method for treating Alzheimer's disease with folic acid |
AU2899099A (en) * | 1998-03-06 | 1999-09-20 | Charles L Brown | Composition for treatment and prevention of coronary artery disease |
-
2000
- 2000-02-03 DE DE10004651A patent/DE10004651A1/en not_active Ceased
- 2000-09-08 WO PCT/EP2000/008801 patent/WO2001056609A1/en active Application Filing
- 2000-09-08 AU AU2000272858A patent/AU2000272858A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE10004651A1 (en) | 2001-08-16 |
WO2001056609A1 (en) | 2001-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002222118A1 (en) | Pharmaceutical compositions for inhalation | |
AU781269C (en) | Pharmaceutical compositions | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU2001274307A1 (en) | Pharmaceutical compositions | |
AU2001271037A1 (en) | Pharmaceutical compositions containing dds compounds | |
AU2001266338A1 (en) | Pharmaceutical compositions for angiogenic therapy | |
AU2002302147A1 (en) | Pharmaceutical composition | |
AU2000272858A1 (en) | Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments | |
AU2001290239A1 (en) | Medicinal composition | |
AU2002221115A1 (en) | Medicinal compositions having improved absorbability | |
HUP0401612A3 (en) | Pharmaceutical composition suitable for treating diabetes | |
HUP0100489A3 (en) | New piperidine-4-sulphonamide compounds, process for their preparation and pharmaceutical compositions containing them | |
AU2001273919A1 (en) | Pharmaceutical compositions | |
AU2002215114A1 (en) | Pharmaceutical compositions for inhalation | |
AU3945501A (en) | Apparatus for dosage of medicaments | |
AU2002306687A1 (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
AU4085201A (en) | Pharmaceutical composition | |
AU2001292578A1 (en) | Pharmaceutical compounds | |
AU2882699A (en) | Stabilizing composition for pharmaceutical dosage forms | |
AU2001278705A1 (en) | Pharmaceutical composition | |
AU3586401A (en) | Pharmaceutical composition | |
AU2002331279A1 (en) | Pharmaceutical composition for treating hypercholesterolaemia | |
AU4698900A (en) | Pharmaceutical compositions for treating malaria | |
HU9902296D0 (en) | Pharmaceutical composition for treating caltification | |
AUPR529701A0 (en) | Pharmaceutical composition |